Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Price to Sales HistoryFair Value
Percentile Rank36
3Y CAGR+5.1%
5Y CAGR-0.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+5.1%/yr
vs -12.0%/yr prior
5Y CAGR
-0.6%/yr
Recent acceleration
Acceleration
+17.1pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 9.60 | +2.0% |
| 2024 | 9.41 | -11.4% |
| 2023 | 10.62 | +28.3% |
| 2022 | 8.28 | +10.8% |
| 2021 | 7.47 | -24.5% |
| 2020 | 9.90 | -26.7% |
| 2019 | 13.50 | -2.3% |
| 2018 | 13.83 | -7.7% |
| 2017 | 14.99 | +42.1% |
| 2016 | 10.54 | - |